NASDAQ: INCY - Incyte

Yield per half year: +28.9%
Sector: Healthcare

Incyte

Underestimation
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
6/10
23.76 48.77 -51.28% 36 -33.99%
P/S 3.84 33.76 -88.62%
P/BV 2.74 4.82 -43.24%
P/FCF 31.96 60.98 -47.59%
Ev/Ebitda 12.19 -22.12 -155.09%
Ev/S 2.98 22.56 -86.78%
Ev/FCF 24.55 68.75 -64.28%
E/P 0.0416 0.0178 134.05%
Efficiency
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
7/10
24.48 4.83 406.82% 15.47 58.22%
ROE 11.51 9.61 19.87%
ROA 8.81 0.3359 2523.18%
ROIC 27.97 7.63 266.37%
ROS 16.17 -25.17 -164.24%
ROCE 15.84 15.33 3.32%
Debt
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0.0423 -3.67 -101.15% -0.0111 -482.71%
Nеt Debt/Ebitda -3.51 -3.44 2.05%
Debt/Ratio 0.0056 0.1972 -97.14%
Debt/Equity 0.0518 1.65 -96.85%
Debt/Net Income 0.0641 10.31 -99.38%
Dividends
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5491 -100% 0 0%
Number of years of dividend growth 0 0.0789 -100%
DSI 0 0.2043 -100%
Average dividend growth 0 0.0591 -100%
Average percentage for 5 years 0 0.4924 -100%
Average percentage for payments 4.88 43.56 -88.81%
Difference from average difference in sector -0.5491
Growth impulse
Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue 5 years
8/10
71.09 -56.89 -224.96%
Growth impulse Ebitda 5 years 90.91 -64.81 -240.27%
Growth impulse Net Income 5 years 33.72 -58.33 -157.81%
Growth impulse FCF 5 years -29.02 -47 -38.26%
Growth impulse EPS 5 years 29.03 -32.41 -189.57%
IP Score
5.45/10

Similar companies

Amgen

Alexion

ABIOMED

Gilead Sciences